Altimmune Launches Clinical Trial of T-COVIDTM, an Investigational Intranasal Immune Modulator for the Treatment of Patients with Early COVID-19
READ MORE:  https://t.co/6O33QqIEvF
#COVID19 #clinicaltrial #investment #investor #stocks #FilingSearch https://t.co/o4yrIWwGof